Atlas Trials

The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease

Clinical trial NCT02422368 · WITHDRAWN

Trial details

NCT number
NCT02422368
Sponsor
Iran University of Medical Sciences
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Thyroid Eye Disease
Start date
2022-09-01
Primary completion
2024-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.